Announced Thu, 9 Jul · 16:44 IST
Reg 74(5) compliance certificate for quarter ended June 30, 2026
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹170.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.2-2.9+0.0-3.0-3.0+2.9————
Up moveDown movePending
AI summary
Mahamaya Lifesciences has submitted a SEBI Regulation 74(5) compliance certificate for the quarter ended June 30, 2026. KFIN Technologies, the company's Registrar and Share Transfer Agent, certified that details of securities dematerialised and rematerialised during the quarter were furnished to BSE, CDSL, and NSDL. This is a standard quarterly compliance filing.
Likely market impact
No material impact on shareholders. Routine regulatory compliance with no effect on stock price or fundamentals.